BE455206A - - Google Patents
Info
- Publication number
- BE455206A BE455206A BE455206DA BE455206A BE 455206 A BE455206 A BE 455206A BE 455206D A BE455206D A BE 455206DA BE 455206 A BE455206 A BE 455206A
- Authority
- BE
- Belgium
- Prior art keywords
- water
- solution
- neutral
- potassium
- ampoules
- Prior art date
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 210000002381 Plasma Anatomy 0.000 claims description 14
- LWIHDJKSTIGBAC-UHFFFAOYSA-K Tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 12
- 239000011780 sodium chloride Substances 0.000 claims description 12
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 230000001264 neutralization Effects 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 229960001031 Glucose Drugs 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 6
- 235000010755 mineral Nutrition 0.000 claims description 6
- 239000011707 mineral Substances 0.000 claims description 6
- 229910000160 potassium phosphate Inorganic materials 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 235000019798 tripotassium phosphate Nutrition 0.000 claims description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 6
- 150000001860 citric acid derivatives Chemical class 0.000 claims description 5
- 238000004090 dissolution Methods 0.000 claims description 5
- 230000001954 sterilising Effects 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L MgCl2 Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 4
- IOLCXVTUBQKXJR-UHFFFAOYSA-M Potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 claims description 4
- VZJVWSHVAAUDKD-UHFFFAOYSA-N Potassium permanganate Chemical compound [K+].[O-][Mn](=O)(=O)=O VZJVWSHVAAUDKD-UHFFFAOYSA-N 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 239000011521 glass Substances 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L mgso4 Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 239000007800 oxidant agent Substances 0.000 claims description 3
- 230000001590 oxidative Effects 0.000 claims description 3
- NPDODHDPVPPRDJ-UHFFFAOYSA-N permanganate Chemical compound [O-][Mn](=O)(=O)=O NPDODHDPVPPRDJ-UHFFFAOYSA-N 0.000 claims description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 2
- QEEAPRPFLLJWCF-UHFFFAOYSA-K Potassium citrate Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 2
- 239000003463 adsorbent Substances 0.000 claims description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L cacl2 Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- 239000001110 calcium chloride Substances 0.000 claims description 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 2
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 150000002314 glycerols Chemical class 0.000 claims description 2
- 150000002334 glycols Chemical class 0.000 claims description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 2
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 2
- 229920005862 polyol Polymers 0.000 claims description 2
- 150000003077 polyols Chemical class 0.000 claims description 2
- 239000001508 potassium citrate Substances 0.000 claims description 2
- 229960002635 potassium citrate Drugs 0.000 claims description 2
- 230000001698 pyrogenic Effects 0.000 claims description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- 150000003892 tartrate salts Chemical class 0.000 claims description 2
- 239000011791 tripotassium citrate Substances 0.000 claims description 2
- 235000015870 tripotassium citrate Nutrition 0.000 claims description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K Trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims 1
- 244000052616 bacterial pathogens Species 0.000 claims 1
- 230000000052 comparative effect Effects 0.000 claims 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 239000012535 impurity Substances 0.000 claims 1
- 150000003893 lactate salts Chemical class 0.000 claims 1
- 239000001509 sodium citrate Substances 0.000 claims 1
- 239000011778 trisodium citrate Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 description 28
- 239000000047 product Substances 0.000 description 12
- 150000002500 ions Chemical class 0.000 description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 3
- 108060008443 TPPP Proteins 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- -1 hydrogen ions Chemical class 0.000 description 2
- 239000000644 isotonic solution Substances 0.000 description 2
- 238000005063 solubilization Methods 0.000 description 2
- DEQJBORXLQWRGV-UHFFFAOYSA-N 2-hydroxypropanoic acid;iron Chemical compound [Fe].CC(O)C(O)=O.CC(O)C(O)=O DEQJBORXLQWRGV-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K 2qpq Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 210000004369 Blood Anatomy 0.000 description 1
- 210000002966 Serum Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000003139 buffering Effects 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000004225 ferrous lactate Substances 0.000 description 1
- 235000013925 ferrous lactate Nutrition 0.000 description 1
- 229940037907 ferrous lactate Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000003204 osmotic Effects 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 230000000087 stabilizing Effects 0.000 description 1
- 230000036977 tonic contraction Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE455206A true BE455206A (de) |
Family
ID=109179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE455206D BE455206A (de) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE455206A (de) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2042381A1 (de) * | 1969-04-28 | 1971-02-12 | Knox Gelatine Inc |
-
0
- BE BE455206D patent/BE455206A/fr unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2042381A1 (de) * | 1969-04-28 | 1971-02-12 | Knox Gelatine Inc |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU82103A1 (fr) | Compositions de contraste pour l'angiographie | |
| BE455206A (de) | ||
| FR2530856A1 (fr) | Procede de concentration des solutions residuaires de centrales nucleaires | |
| Rowe et al. | In vitro protection of amphibian gastric mucosa by nutrient HCO3− against aspirin injury | |
| Pope et al. | XCVI.—The resolution of benzoylalanine into its optically active components | |
| BE489529A (fr) | Procédé pour la préparation des chlorites solides | |
| Harjula et al. | Effects of synthetic blood combined with contrast medium on coronary endothelium: an experimental study | |
| CA2070856C (fr) | Procede de purification d'une solution aqueuse de chlorure de metal alcalin par enlevement de l'ammonium et de l'iode | |
| BE409619A (de) | ||
| SU267287A1 (ru) | Паста для химической обработки поверхности титана и его сплавов | |
| BE446238A (de) | ||
| CA1304943C (fr) | Procede pour la production de metaux par reduction de sels metalliques | |
| BE1017688A6 (fr) | Compositions pharmaceutique et son dispositif medical pour le traitement de lesions cutanees. | |
| BE653541A (fr) | Procede de traitement d'amelioration des matieres cellulaires en polyurethanes | |
| Veerakul et al. | Fatal penetrating aortic ulcer and aorto-iliac occlusion mimics acute coronary syndrome: A case report and literature review | |
| BE446867A (de) | ||
| Kyösola et al. | Cardioplegic protection with hypothermic K-Fluosol DA and K/Mg-Fluosol DA solutions | |
| JP5833579B2 (ja) | アルカリハロゲン化物を用いて無機ヒドロゲルを製造する方法 | |
| BE705135A (de) | ||
| BE529550A (de) | ||
| BE439685A (de) | ||
| Schaeffer et al. | Influence of several solutions used in bypass surgery on the permeability of the endothelium of carotid arteries in New Zealand rabbits | |
| Florkln | Submicrodosage Photométrique De L'agide Urique Des Plasmas Sanguins | |
| BE402585A (de) | ||
| BE435347A (de) |